Cochlear Implant Bilateral denied as duplicate or overlapping therapy by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for cochlear implant bilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denies a Second Cochlear Implant as Duplicate Therapy

Blue Cross Blue Shield may issue a duplicate-therapy denial for bilateral cochlear implantation — meaning the second implant — on the basis that cochlear implantation has already been performed on the other ear and the plan considers the second procedure a repetition of a service already received. This denial type is particularly common when the second implant is requested in a separate authorization cycle or after a significant gap in time from the first.

## Why This Denial Is Appealable

Bilateral cochlear implants serve two anatomically and functionally distinct ears. The second implant is not a repetition of the first — it provides directional hearing, improved speech understanding in background noise, and redundancy that a single implant cannot replicate. Professional societies in otolaryngology and audiology have documented functional outcomes that are meaningfully different with bilateral versus unilateral implantation. If BCBS has applied a duplicate-therapy label to what is clinically a sequential bilateral procedure, that determination is factually incorrect and directly appealable.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 (employer plans) or applicable state law within the deadline stated on your denial notice — typically 180 days.
• External review: ACA §2719 provides independent external review after internal exhaustion. The general window is approximately four months from the final internal denial; confirm your exact deadline on the denial notice.
• Expedited review: If delay poses a serious risk to the patient's communicative development or safety (particularly in children), request expedited external review — decisions typically within 72 hours.

## Concrete Appeal Steps

1. Obtain the EOB and denial letter identifying the specific claim or prior authorization BCBS believes the requested service duplicates. 2. Have the implanting surgeon and audiologist write letters explaining that the two ears are distinct anatomical structures, that bilateral implantation serves different functional goals than unilateral, and that the second implant is independently medically necessary. 3. Document the residual functional limitations of unilateral implantation in this specific patient — audiologic testing results, speech-in-noise performance, or directional hearing assessments from the medical record. 4. Check whether BCBS's medical policy specifically addresses bilateral cochlear implants and cite that policy's own language in the appeal.

## Documentation to Gather

• Diagnosis records confirming bilateral sensorineural hearing loss
• Audiologic evaluation results for the unimplanted ear demonstrating ongoing functional impairment
• Implanting surgeon and audiologist letters explaining the clinical distinction between unilateral and bilateral implantation and the specific functional goals of the second implant
• Clinical guidelines from the American Academy of Otolaryngology–Head and Neck Surgery or other relevant specialty society supporting bilateral implantation
• Functional assessment of the existing (first-side) implant, including its limitations in real-world listening environments

## Criteria-Mapping Structure

Obtain BCBS's current medical policy for cochlear implants, specifically any section addressing bilateral procedures. Copy each coverage criterion for the second implant. For each criterion, provide a direct response: cite the specific audiologic finding, date, and clinical note that satisfies it. Address any language about the "duplicate" nature of the second procedure by citing the surgeon's and audiologist's documentation of distinct functional purpose.